
09/11/2024
A new KFF analysis (https://www.kff.org/health-costs/issue-brief/how-many-adults-with-private-health-insurance-could-use-glp-1-drugs) revealed that over 40% of privately insured adults under 65 could be eligible for GLP-1 treatments.
As GLP-1 medications reshape the healthcare landscape, employers need expert guidance. We’re partnering with Crain's Grand Rapids Business, bringing together a panel of experts to discuss the impact of GLP-1s on employers.
Register now, and we’ll see you next Thursday, Sep. 19, at 1 p.m. ET: https://event.webcasts.com/starthere.jsp?ei=1684766&tp_key=848744d4aa